124 related articles for article (PubMed ID: 11078828)
1. Elevated serum soluble CD44 level in sarcoidosis.
Kasuga I; Minemura K; Nasu H; Hibi N; Tago H; Nagate A; Kunisawa A; Ohyashiki JH; Ohyashiki K
Int J Mol Med; 2000 Dec; 6(6):679-82. PubMed ID: 11078828
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes.
Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K
Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
Amirghofran Z; Asiaee E; Kamazani FM
Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subset.
Komura K; Sato S; Fujimoto M; Hasegawa M; Takehara K
Rheumatology (Oxford); 2002 Oct; 41(10):1149-54. PubMed ID: 12364635
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble CD44 in pediatric patients with acute leukemia.
Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.
Homolka J; Lorenz J; Zuchold HD; Müller-Quernheim J
Clin Investig; 1992 Oct; 70(10):909-16. PubMed ID: 1280495
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
Sasaki K; Niitsu N
Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
[TBL] [Abstract][Full Text] [Related]
10. Levels of transferrin in bronchoalveolar lavage fluid in sarcoidosis.
Shigemura M; Nasuhara Y; Konno S; Hattori T; Shimizu C; Matsuno K; Nishimura M
Lung; 2010 Apr; 188(2):151-7. PubMed ID: 20066543
[TBL] [Abstract][Full Text] [Related]
11. Elevated level of soluble interleukin-2 receptor in bronchoalveolar lavage fluid from sarcoidosis patients.
Ogushi F; Sone S; Singh SM; Tani K; Ozaki T; Yasuoka S; Ogura T; Honda M
Jpn J Med; 1991; 30(2):113-7. PubMed ID: 1678021
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CD44 on alveolar eosinophils with high concentrations of soluble CD44 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia.
Katoh S; Taniguchi H; Matsubara Y; Matsumoto N; Fukushima K; Kadota J; Matsukura S; Kohno S
Allergy; 1999 Dec; 54(12):1286-92. PubMed ID: 10688432
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
Mroz RM; Korniluk M; Stasiak-Barmuta A; Chyczewska E
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():507-13. PubMed ID: 19218675
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD44 concentration in the serum and peritoneal fluid samples of patients with different stages of endometriosis.
Mashayekhi F; Aryaee H; Mirzajani E; Yasin AA; Fathi A
Arch Gynecol Obstet; 2015 Sep; 292(3):641-5. PubMed ID: 25711649
[TBL] [Abstract][Full Text] [Related]
15. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis.
Lawrence EC; Brousseau KP; Berger MB; Kurman CC; Marcon L; Nelson DL
Am Rev Respir Dis; 1988 Apr; 137(4):759-64. PubMed ID: 3128148
[TBL] [Abstract][Full Text] [Related]
16. Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis?
Cohen RD; Bunting PS; Meindok HO; Chamberlain DW; Rebuck AS
Thorax; 1985 Jul; 40(7):497-500. PubMed ID: 2994247
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
Specks U; Martin WJ; Rohrbach MS
Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
[TBL] [Abstract][Full Text] [Related]
18. Elevated tenascin-C levels in bronchoalveolar lavage fluid of patients with sarcoidosis.
Fujita H; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Hara A; Mukae H; Kohno S
Lung; 2012 Oct; 190(5):537-43. PubMed ID: 22760918
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S
Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of soluble ICAM-1 in serum and BAL fluid in patients with active sarcoidosis.
Ishii Y; Kitamura S
Chest; 1995 Jun; 107(6):1636-40. PubMed ID: 7781359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
